Moderna (MRNA) EBT Margin (2017 - 2026)
Moderna (MRNA) reported EBT Margin of 342.93% for Q1 2026, up 54966.0% year-over-year from N/an in Q1 2025, and down 191.0% quarter-over-quarter from 117.85% in Q4 2025.
Moderna (MRNA) EBT Margin (2017 - 2026) Analysis & Trends
Moderna (MRNA) has 10 years of EBT Margin data on file, last reported at 342.93% in Q1 2026.
- EBT Margin for Q1 2026 came in at 342.93%, up 54966.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 141.03% (down 3159.0% YoY), and the FY2025 annual result was 142.39%, down 3092.0% from the prior year.
- EBT Margin eased to 342.93% in Q1 2026 per MRNA's latest filing, from 117.85% in the prior quarter.
- Over five years, EBT Margin peaked at 69.72% in Q1 2022 and troughed at 892.59% in Q1 2025.
- A 5-year average of 231.31% and a median of 106.94% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2026: EBT Margin plunged 68122 bps in 2024, then soared 54966 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 32.55% in 2022, then tumbled by 92 bps to 2.49% in 2023, then tumbled by 5022 bps to 122.57% in 2024, then grew by 4 bps to 117.85% in 2025, then tumbled by 191 bps to 342.93% in 2026.
- Business Quant data shows MRNA's EBT Margin at 342.93% in Q1 2026, 117.85% in Q4 2025, and 18.41% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -342.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -342.93% |
| Dec 31, 2025 | -117.85% |
| Sep 30, 2025 | -18.41% |
| Jun 30, 2025 | -576.06% |
| Mar 31, 2025 | -892.59% |
| Dec 31, 2024 | -122.57% |
| Sep 30, 2024 | 1.13% |
| Jun 30, 2024 | -726.70% |
| Mar 31, 2024 | -697.60% |
| Dec 31, 2023 | 2.49% |
| Sep 30, 2023 | -106.94% |
| Jun 30, 2023 | -508.43% |
| Mar 31, 2023 | -16.38% |
| Dec 31, 2022 | 32.55% |
| Sep 30, 2022 | 36.18% |
| Jun 30, 2022 | 52.10% |
| Mar 31, 2022 | 69.72% |
| Dec 31, 2021 | 75.02% |
| Sep 30, 2021 | 71.48% |
| Jun 30, 2021 | 70.35% |